A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
Clinical trial NCT01876381 · COMPLETED
Trial details
- NCT number
- NCT01876381
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-02-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.